{"data":[{"accessionNo":"0000315066-26-002294","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","cusip":"159864107","securityClass":"COMMON STOCK","eventDate":"2026-08-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":4865628.13,"percentOfClass":10.2,"filedAt":"2026-09-08"},{"accessionNo":"0000315066-26-002294","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","cusip":"159864107","securityClass":"COMMON STOCK","eventDate":"2026-08-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":4865628.13,"percentOfClass":10.2,"filedAt":"2026-09-08"},{"accessionNo":"0000914208-26-000275","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International Inc","ticker":"CRL","cusip":"159864107","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Invesco Ltd.","reportingCik":null,"personType":"HC,IA","sharesOwned":2984785,"percentOfClass":6.2,"filedAt":"2026-08-13"},{"accessionNo":"0000315066-26-001960","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","cusip":"159864107","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":4239751.47,"percentOfClass":8.8,"filedAt":"2026-08-06"},{"accessionNo":"0000315066-26-001960","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","cusip":"159864107","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":4239751.47,"percentOfClass":8.8,"filedAt":"2026-08-06"},{"accessionNo":"0000315066-26-001147","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001100682","issuerName":"CHARLES RIVER LABS INTL INC","ticker":"CRL","cusip":"159864107","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3456244.72,"percentOfClass":7,"filedAt":"2026-05-06"},{"accessionNo":"0000315066-26-001147","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001100682","issuerName":"CHARLES RIVER LABS INTL INC","ticker":"CRL","cusip":"159864107","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3456244.72,"percentOfClass":7,"filedAt":"2026-05-06"},{"accessionNo":"0000914208-26-000115","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International Inc","ticker":"CRL","cusip":"159864107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Invesco Ltd.","reportingCik":null,"personType":"HC,IA","sharesOwned":2397252,"percentOfClass":4.9,"filedAt":"2026-05-06"},{"accessionNo":"0002100119-26-000348","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International Inc","ticker":"CRL","cusip":"159864107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":3634376,"percentOfClass":7.38,"filedAt":"2026-04-29"},{"accessionNo":"0000102909-26-000971","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International Inc","ticker":"CRL","cusip":"159864107","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0000914208-26-000032","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International Inc","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Invesco Ltd.","reportingCik":null,"personType":"HC,IA","sharesOwned":2696150,"percentOfClass":5.5,"filedAt":"2026-02-12"},{"accessionNo":"0000902219-26-000050","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":1749213,"percentOfClass":3.6,"filedAt":"2026-02-10"},{"accessionNo":"0000902219-26-000050","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":1749213,"percentOfClass":3.6,"filedAt":"2026-02-10"},{"accessionNo":"0000902219-26-000050","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":1749213,"percentOfClass":3.6,"filedAt":"2026-02-10"},{"accessionNo":"0000905148-25-004067","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"NOMURA HOLDINGS INC","reportingCik":null,"personType":"HC","sharesOwned":807923,"percentOfClass":1.6,"filedAt":"2025-11-14"},{"accessionNo":"0000902219-25-000431","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":3190467,"percentOfClass":6.5,"filedAt":"2025-11-12"},{"accessionNo":"0000902219-25-000431","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3190467,"percentOfClass":6.5,"filedAt":"2025-11-12"},{"accessionNo":"0000902219-25-000431","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3190467,"percentOfClass":6.5,"filedAt":"2025-11-12"},{"accessionNo":"0000902219-25-000431","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":3190467,"percentOfClass":5.7,"filedAt":"2025-11-12"}],"updatedAt":"2026-10-15T03:18:58.739Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}